With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Human Papillomavirus or HPV is one of the most common sexually transmitted infections. The infection is important to prevent because it can cause cervical cancer and genital warts.…
Rallie McAllister, MD, MPH, CBR Spokesperson and Co-author of The Mommy MD Guides, discusses the limitless possibilities offered by cord blood banking. Regenerative medicine, in particular, is a…
Cord blood contains a plethora of stem cells with the potential for healing and regeneration. But what are the advantages of using cord blood stem cells over other…
Many patients do not know about the uses and potential of umbilical cord blood. Rallie McAllister, MD, MPH, CBR Spokesperson and Co-author of The Mommy MD Guides, discusses…
The Women’s Health Initiative launched a hormone therapy trial in the 1990s and follow-up continued with the women participating in the trials. A new study describes the long-term…
NEW YORK (Reuters Health) – In a phase III, multinational study of patients with heavily pretreated metastatic breast cancer, adding sunitinib to capecitabine provided no benefit, and in…
NEW YORK (Reuters Health) – The results of a phase III Italian study indicate that the risk of breast cancer in postmenopausal women who use hormone replacement therapy…
By Andrew M. Seaman NEW YORK (Reuters Health) – Low-dose aspirin, even if not taken daily, may reduce a woman’s risk of colon cancer over the long term,…
NEW YORK (Reuters Health) – Physicians caring for women who are at increased risk for breast cancer should discuss with them the risks and benefits of specific chemoprevention…
NEW YORK (Reuters Health) – The cumulative incidence of osteonecrosis of the jaw was about 2% over 6 years among women with early breast cancer who received intensive…
